110 results
Page 2 of 6
8-K
EX-99.1
qsej lt40
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
EX-99.1
xh3stv6sgc 5fhf2nm
27 Apr 22
Repligen Reports First Quarter 2022 Financial Results
7:47am
8-K
EX-99.1
hq5nxvyoeei8n
17 Feb 22
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
7:49am
8-K
EX-99.1
tvr8f1gmyqrt8qe
28 Oct 21
Repligen Reports Third Quarter 2021 Financial Results
7:55am
8-K
EX-99.1
t6632yo
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am
8-K
EX-99.1
5yjxqa40t5rscn
27 Jul 21
Repligen Reports Second Quarter 2021 Financial Results
7:42am
DEFR14A
w8x5drqtfj
5 May 21
Revised proxy
4:16pm
8-K
EX-99.1
16dbps7icanzdy vpk
4 May 21
Repligen Reports First Quarter 2021 Financial Results
7:54am
8-K
EX-99.1
ej7gn84twez
24 Feb 21
Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
7:54am
8-K
EX-99.1
quexn 3hhxv8v
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
8-K
EX-99.2
yq31v5tq0
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
8-K
EX-99.1
duysp9hf43mmh ibtr
5 Nov 20
Repligen Reports Third Quarter 2020 Financial Results
7:51am